|

Inotuzumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BESPONSA®, Inotuzumab ozogamicin

Pipeline

Phase 2: 1

Top Sponsors

  • St. Jude Children's Research Hospital1

Indications

  • Lymphoblastic Lymphoma1
  • Acute Lymphoblastic Leukemia1
  • Cancer1

Tulsa, Oklahoma1 trial

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Saint Francis Children's Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.